APA (7th ed.) Citation

LE, A., A, M., A, I., & A, C. (2026). Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Facts and Hopes. Journal of clinical and experimental hepatology, 16(1), 103411. https://doi.org/10.1016/j.jceh.2025.103411

Chicago Style (17th ed.) Citation

LE, Adinolfi, Marrone A, Izzi A, and Craxì A. "Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Facts and Hopes." Journal of Clinical and Experimental Hepatology 16, no. 1 (2026): 103411. https://doi.org/10.1016/j.jceh.2025.103411.

MLA (9th ed.) Citation

LE, Adinolfi, et al. "Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Facts and Hopes." Journal of Clinical and Experimental Hepatology, vol. 16, no. 1, 2026, p. 103411, https://doi.org/10.1016/j.jceh.2025.103411.